LCM
IMGN

Laurion Capital Management’s Immunogen Inc IMGN Stock Holding History

Laurion Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-64,930
Closed -$1.93M – 663
2023
Q4 		$1.93M Buy
+64,930
New +$1.29M 0.02% 299
2018
Q2 		– Sell
-13,700
Closed -$144K – 1647
2018
Q1 		$144K Buy
+13,700
New +$135K ﹤0.01% 1255

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Laurion Capital Management's IMGN Position: Q1 2024 in Review

Laurion Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 64,930 shares — an estimated $1.93M sold.

Laurion Capital Management first reported a position in IMGN in Q1 2018 and held it in 2 quarters. The position peaked at $1.93M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Laurion Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Laurion Capital Management sold 64,930 Immunogen Inc shares in Q1 2024, an estimated $1.93M.
  • Laurion Capital Management first reported a position in Immunogen Inc in Q1 2018 and held it in 2 quarters.
  • Laurion Capital Management's Immunogen Inc position peaked at $1.93M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Laurion Capital Management's 13F filing for Q1 2024, filed 15 May 2024.